Charles J. Casamento - 01 Jun 2021 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Charles J. Casamento
Issuer symbol
RLMD
Transactions as of
01 Jun 2021
Net transactions value
-$100,020
Form type
4
Filing time
02 Jun 2021, 17:00:59 UTC
Previous filing
22 Jun 2021
Next filing
16 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Sale $17,721 -520 -5.2% $34.08 9,430 01 Jun 2021 Direct F1, F2, F3
transaction RLMD Common Stock Sale $82,300 -2,480 -26% $33.19 6,950 01 Jun 2021 Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
F2 The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
F3 Sales prices range from $33.84 to $34.54 per share, inclusive.
F4 Sales prices range from $32.85 to $33.42 per share, inclusive.